PRECISE-DAPT score
Also written as: PRECISE-DAPT — PREdicting bleeding Complications In patients undergoing Stent implantation and subsEquent Dual Anti Platelet Therapy
Clinical tool for determining optimal duration of dual antiplatelet therapy after coronary stenting based on bleeding risk.
Full Definition
The PRECISE-DAPT (PREdicting bleeding Complications In patients undergoing Stent implantation and subsEquent Dual Anti Platelet Therapy) score is a validated risk assessment tool that guides the duration of dual antiplatelet therapy following percutaneous coronary intervention. This scoring system incorporates five clinical variables: age, creatinine clearance, hemoglobin level, white blood cell count, and prior spontaneous bleeding. Patients with PRECISE-DAPT scores ≥25 are considered high bleeding risk and may benefit from shorter DAPT duration (3-6 months), while those with lower scores can safely continue longer DAPT courses (12 months or more). The tool helps personalize antithrombotic therapy by balancing ischemic protection against bleeding complications in post-PCI patients.
Usage
Usage note: Always hyphenate PRECISE-DAPT; include 'score' when referencing the risk calculation tool.
In Context
- "The PRECISE-DAPT score of 32 suggested limiting dual antiplatelet therapy to 3 months duration." — Post-PCI management plan
- "Based on the low PRECISE-DAPT score, extended DAPT for 12 months was recommended." — Discharge planning note